NumFin

Huapont Life Sciences Co., Ltd.

符号: 002004.SZ

SHZ

4.42

CNY

今天的市场价格

  • 32.7334

    市盈率

  • 0.7053

    PEG比率

  • 8.58B

    MRK市值

  • 0.05%

    DIV收益率

Huapont Life Sciences Co., Ltd. (002004-SZ) 财务报表

Download
年度季度
线性对数
在图表中，您可以看到 的动态默认数字 Huapont Life Sciences Co., Ltd. (002004.SZ). 的默认数据。公司收入显示 4719.527 M 的平均值，即 0.415 % 增长率。整个期间的平均毛利润为 1826.221 M，即 0.211 %. 平均毛利率为 0.518 %. 公司去年的净收入增长率为 -0.732 %，等于 0.246 % % 整个公司历史的平均增长率.,

年度季度
10Y20Y30Y40Y

资产负债表

深入分析 Huapont Life Sciences Co., Ltd. 的财务轨迹，我们可以看到其平均资产增长率。有趣的是，这一增长率为 ，反映了公司的高点和低点。与季度相比，这一数字调整为0. 回顾过去一年，总资产变化为 0.023. 在流动资产领域，002004.SZ 的报告货币为11387.4. 这些资产中的很大一部分，即 4413.135 是现金和短期投资。与去年的数据相比，该部分的变化率为-0.098%. 公司的长期投资虽然不是其重点，但以报告货币计算的2253.482（如果有的话）为2253.482。这表明与上一报告期相比，0.870% 的差异反映了公司的战略转变. 公司的债务概况显示，以报告货币计算的长期债务总额为 2932.089. 这一数字表明，0.072% 的年同比变化. 股东权益总额所体现的股东价值是以报告货币计算的 10105.177. 这方面的年同比变化率为 -0.009%. 深入了解公司财务信息后，会发现更多细节。应收账款净额的估值为2844.748，存货估值为 2674.61，商誉估值为 2739.93（如有. 无形资产总额（如果有）按 1652.44 估值. 应付账款和短期债务分别为 2702.85 和 5693.76. 债务总额为8625.84，债务净额为 4842.99. 其他流动负债为 29.69，加上总负债 14142.66. 最后，如果存在推荐股票，则其估值为 84.95.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001

balance-sheet.row.cash-and-short-term-investments

18416.544413.14892.95416.6
4984.7
4051.3
4348.9
7706.6
6032.9
5965
2773.5
1245.3
853
657.4
146.9
165.4
184.1
160.5
106
132.9
240.1
33.4
36.7
23.1

balance-sheet.row.short-term-investments

2174.44630.3706.31030.4
862.3
684.9
-1317.4
0.2
-650.1
-160.6
2.8
79.2
87.9
0
0.2
0
0
0
7.6
7.3
3.6
0
0
0

balance-sheet.row.net-receivables

12013.252844.73059.73587.9
2777.3
2921
3276.9
3708.8
3119.4
2150.5
1379.8
1454.9
1489.1
943.1
170.5
145.8
135.1
286
68.8
65.8
64.6
36.3
76.5
34.9

balance-sheet.row.inventory

10688.672674.62535.62402.3
1951
2092.1
1949.9
1933.8
1502.6
1212.5
942.3
675.6
551.5
400
144.6
116.5
105.4
93.8
84.2
20.1
19.8
17.3
29.4
32.7

balance-sheet.row.other-current-assets

5150.151454.91066907.2
1090
994.5
1426.1
1339.6
1874.4
245.8
352.6
93.4
-158.3
-126.5
-34.3
-11.3
-9.3
-60.1
0.2
-12.1
-14.5
-1.7
-2.7
-4.1

balance-sheet.row.total-current-assets

46268.6111387.411554.212314.1
10803
10058.8
11001.8
14688.9
12529.2
9573.8
5448.2
3469.3
2735.3
1874
427.7
416.4
415.3
480.1
259.2
206.7
310
85.3
139.9
86.5

balance-sheet.row.property-plant-equipment-net

38610.8810024.58917.68052.8
7628.5
7098.6
6331.7
5224.1
3141.3
3226.6
2824.9
1613.6
1304.6
824.4
417.8
402.5
421.6
402.1
324.4
144.5
118.1
52
48.2
40.8

balance-sheet.row.goodwill

11376.062739.92948.13439.9
3465.1
3465.1
3531.2
3606.2
3124.1
2984.7
1678.3
1072.4
949.6
869.4
21.9
21.9
23.1
30.7
0
0
0
0
0
0

balance-sheet.row.intangible-assets

6781.251652.41759.31731
1644
1461
1493.2
1485.9
1289.1
1183.5
569
414.6
395.1
235.9
99.4
62.3
63.9
89.4
77.4
51.3
48
71
1.5
0.3

balance-sheet.row.goodwill-and-intangible-assets

18157.314392.44707.45170.9
5109.1
4926.1
5024.4
5092.1
4413.2
4168.2
2247.3
1486.9
1344.7
1105.3
121.4
84.2
87
120.1
77.4
51.3
48
71
1.5
0.3

balance-sheet.row.long-term-investments

9562.982253.522341503.3
1742.5
1805.6
3531.1
2247.5
3628.1
2329.5
2696.1
909.6
367.7
0
360.5
0
0
0
95.4
67
1.1
0
0
0

balance-sheet.row.tax-assets

1649.71434337.1266.2
355
338.8
274.9
255
153.3
111.7
67.9
23
24.4
15.9
13.7
9.9
12.3
10.3
0
0
3.6
0
0
0

balance-sheet.row.other-non-current-assets

8760.432235.62274.12737.1
2588
2408.6
387.7
1582.5
362.7
300.6
283.7
145.2
145.5
369.8
17.3
230.1
203.2
76
8.6
8.3
0.3
17.5
17.5
5.8

balance-sheet.row.total-non-current-assets

76741.321934018470.217730.4
17423.1
16577.6
15549.7
14401.2
11698.7
10136.6
8119.9
4178.4
3186.9
2315.4
930.7
726.6
724
608.5
505.8
271.2
171.1
140.4
67.2
47

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

123009.9330727.430024.430044.4
28226.1
26636.4
26551.5
29090
24227.9
19710.4
13568.1
7647.6
5922.2
4189.4
1358.4
1143
1139.3
1088.6
765.1
477.9
481
225.7
207.1
133.4

balance-sheet.row.account-payables

9675.352702.92374.82439.3
1758.8
1527.7
1762.7
1956.2
1730.5
1178.9
1261.3
1032
1033.8
665.1
75.7
40.7
77.4
34
29.7
6.8
18.5
11
4.9
6.4

balance-sheet.row.short-term-debt

24167.285693.862646294.5
7294.8
6908.1
6972.7
6005
6284.7
2760.3
2941.4
1480.9
1318.6
632.7
114.5
84.2
151.6
199
125.6
0
22
35
68
13

balance-sheet.row.tax-payables

916.31177313.2226.6
223.8
189.1
206.8
157.2
89.3
89.4
61.8
-20.6
-24.3
11.6
21.2
21.1
21.5
20.1
3.6
3.5
6.7
2.8
3.6
6

balance-sheet.row.long-term-debt-total

10912.672932.11783.72273.2
1838.6
2013.6
2752.1
5499.5
2695.3
3558.2
3025.9
124.1
21.8
46
1.2
1.7
1.7
32.3
5
0
0
10
0
5

Deferred Revenue Non Current

1144.41271.2278.2258.1
224.9
152.7
142.7
112.9
99.8
78.4
61.2
64.5
92.6
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

430.25---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

149.5929.72134.1469
756.7
1018.4
572.4
969.6
1991
1066.4
47
418.8
46.3
29.8
11.3
7.8
8.8
3.3
7.6
25.3
4.1
1.5
0.8
0.8

balance-sheet.row.total-non-current-liabilities

13263.793508.923622831.4
2368.6
2432.4
3151.4
5810.4
2902.9
3741.9
3241.1
330.1
219.2
116.4
22.6
29.4
17.6
44.1
12.9
5
9.3
19.3
0.6
6.1

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

189.0347.641.951.6
34.9
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

56250.3814142.713473.614220.7
14089.4
13392.7
13802.3
15793.4
13523.6
9300
7836.2
3635.3
2965.4
1603.5
322.6
245.7
325.3
357.8
242.2
37.2
79.4
80
104.9
45.9

balance-sheet.row.preferred-stock

84.9584.900
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

7919.681979.91979.91979.9
1979.9
1979.9
2034.8
2034.8
2034.8
2034.9
675.7
580.7
502.5
167.5
132
132
132
132
132
132
132
66
66
66

balance-sheet.row.retained-earnings

9945.122336.82544.82646.9
2464.5
2309
2182.7
2127.1
1953.8
1841.5
1456.9
1258
1152.9
923.1
627.9
507.7
427.3
345.9
138.9
126
81.7
59.5
25.5
18.3

balance-sheet.row.accumulated-other-comprehensive-income-loss

12339.24-84.9890.3719.2
689.5
654.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

10549.875788.547774763.4
4495.6
4397.5
4847.4
5331
5656.6
5646.8
3443.2
1958.5
1027.3
1302.5
215.6
198.3
193.7
191.8
179.8
172.8
164.6
19.1
9.1
3.2

balance-sheet.row.total-stockholders-equity

40838.8510105.21019210109.4
9629.5
9340.8
9064.9
9493
9645.2
9523.1
5575.7
3797.3
2682.7
2393.1
975.5
838
753
669.7
450.7
430.9
378.4
144.6
100.7
87.5

balance-sheet.row.total-liabilities-and-stockholders-equity

123009.9330727.430024.430044.4
28226.1
26636.4
26551.5
29090
24227.9
19710.4
13568.1
7647.6
5922.2
4189.4
1358.4
1143
1139.3
1088.6
765.1
477.9
481
225.7
207.1
133.4

balance-sheet.row.minority-interest

25920.716479.66358.85714.4
4507.2
3903
3684.2
3803.6
1059
887.3
156.2
215
274.2
192.9
60.3
59.3
61
61.2
72.2
9.8
23.3
1.2
1.5
0

balance-sheet.row.total-equity

66759.5616584.716550.815823.7
14136.7
13243.7
12749.2
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

123009.93---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

11737.432883.82940.32533.7
2604.7
2490.4
2213.7
2247.7
2978
2168.9
2698.9
988.8
455.6
307.1
360.7
213.3
202.2
75.1
103
74.3
4.7
17.1
17.1
5.3

balance-sheet.row.total-debt

35079.958625.88047.78567.7
9133.4
8921.7
9724.9
11504.5
8980
6318.5
5967.4
1605
1340.4
678.7
115.7
85.9
153.3
231.3
130.6
0
22
45
68
18

balance-sheet.row.net-debt

18837.8548433861.14181.5
5011
5555.3
5376
3798.1
2947.1
353.5
3196.6
438.9
575.3
21.3
-30.9
-79.5
-30.8
70.8
32.3
-125.7
-214.5
11.6
31.3
-5.1

现金流量表

在 Huapont Life Sciences Co., Ltd. 的财务状况中，自由现金流在过去一段时间内发生了显著变化，呈现出 -0.761 的转变。该公司最近通过发行 0 扩大了股本，与上一年相比出现了0.000 的差异. 有趣的是，公司的部分股票，特别是 0，是由公司自己回购的。这一举动导致0.000 比上一年有所变化。同时，以报告货币计算，公司的应付账款目前为 1.46. 公司的投资活动产生了现金使用净额，按报告货币计算达到-556492650.870. 与上一年相比， -0.296 发生了变化. 在同一时期，公司记录了 800.23, -176.39 和 -7897.82，这对于了解公司的投资和还款策略具有重要意义. 公司的融资活动导致使用的现金净额为0.000，同比差异为0.000. 此外，公司还将-854.41 用于向股东分红。与此同时，该公司还采取了其他财务措施，即 7381.97，这也对其在此期间的现金流产生了重大影响. 这些组成部分合在一起，全面反映了公司的财务状况和现金流管理的战略方针。

common:word.in-mln

USD
Growth
TTM202220212020201920182017201620152014201320122011201020092008200720062005200420032002

cash-flows.row.net-income

280.541126.7925895
931.9
822.8
593.7
611.7
656.8
446
317
370.8
308.4
135.2
129.2
90.1
222.6
58.9
51.9
46.9
39.6
36.8

cash-flows.row.depreciation-and-amortization

696.35800.2747.9696.3
607.1
586.8
387.2
330.8
319.8
210.5
132.4
106.4
39.3
36.6
41.8
38
28.6
13.2
12.2
8.1
6.1
4.4

cash-flows.row.deferred-income-tax

0-68.611.4-25.5
-60.7
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

049.5-11.413
8.8
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

-800.57-162.1-843.9294.8
28.8
-30.7
-660.8
-654.6
-741.5
-312.2
-185.8
-194.5
-12.1
-58.7
-17.4
1.3
-4.2
-0.1
-19.7
14.3
4.7
-9.2

cash-flows.row.account-receivables

-587.9859.6-1039.7-128.8
-29.7
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

-201.92-154.6-456.1142.2
-144.9
-15.3
-36.7
-320.8
-148.5
-162.5
-84.7
-32.3
-10.5
-29.8
-15
-25
-9.7
-6.7
-0.1
-2.3
12
3.2

cash-flows.row.account-payables

01.5645.4306.9
264
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

-10.67-68.66.4-25.5
-60.7
-15.3
-624.1
-333.8
-593
-149.7
-101.1
-162.2
-1.6
-28.9
-2.4
26.2
5.5
6.6
-19.7
16.6
-7.2
-12.4

cash-flows.row.other-non-cash-items

1553.85662.1440.7499.1
566.2
529.7
271.4
224.1
107.3
111.7
85.9
-24.9
-200.4
-33.2
-30.1
-15.6
-167.8
-5.9
-0.7
1.2
6.3
4.9

cash-flows.row.net-cash-provided-by-operating-activities

1730.18000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

-1379.1-1131.2-1256.4-1231.2
-1433.5
-1099.4
-972.7
-651.2
-831.8
-585.5
-379.8
-315.2
-95.8
-56.9
-73.5
-92.5
-124
-47.8
-44.4
-26.8
-30.8
-52.7

cash-flows.row.acquisitions-net

16.29-15.8-40.129.8
64.7
-15.4
-172.6
-187.7
-37.2
-191.1
-115.7
-171.8
211.3
0.3
25.8
2.5
0.7
0.8
0.1
0
0
0

cash-flows.row.purchases-of-investments

-8385.3-7141.8-7267.4-10125.4
-7001.5
-9954
-7235.2
-5852.7
-1196.1
-3693
-851.2
-143.7
-106.5
-138.1
-39
-72
-411.3
-122.9
-90.1
0
0
-13.2

cash-flows.row.sales-maturities-of-investments

7625.577908.87749.19612.7
6969.8
9774.9
7656.3
3526.8
1521.3
1778.9
299.4
55.1
38.8
42.1
51.5
91.9
427.5
40.5
4.3
0
0
0

cash-flows.row.other-investing-activites

-161.49-176.424.4-46.2
41.3
268.5
1066.7
138.8
-112.8
6.2
18.1
-10.7
30.8
-34.9
11.5
10.5
4.5
27.6
2
19.9
4
0.2

cash-flows.row.net-cash-used-for-investing-activites

-2275.27-556.5-790.4-1760.3
-1359.2
-1025.5
342.5
-3026
-656.6
-2684.5
-1029.3
-586.3
78.7
-187.5
-23.6
-59.6
-102.7
-101.7
-128.1
-6.9
-26.8
-65.7

cash-flows.row.debt-repayment

-6196.07-7897.8-10279-11984.1
-10747.2
-8972.5
-10000.8
-5988.2
-4494.4
-3215.5
-1978.7
-936.2
-174.7
-122.5
-188
-323.4
-134.2
0
-26
-107
-73
-13

cash-flows.row.common-stock-issued

000-4.6
-5.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-repurchased

0004.6
5.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

-761.1-854.4-859.4-943.1
-966.5
-988
-761.5
-783.6
-517.9
-408.2
-270.2
-185.2
-14.1
-10.2
-52.4
-19
-14.4
-40.4
-0.4
-19.2
-19.7
-9.7

cash-flows.row.other-financing-activites

5333.16738210934.712687.6
10085.9
6751.9
11794.8
8615.4
8085.2
5937.7
3425.9
1364.7
354.5
204.8
129.9
298.3
232.8
48.7
0
265.6
59.6
65.1

cash-flows.row.net-cash-used-provided-by-financing-activities

734.91-1370.3-203.8-239.6
-1627.8
-3208.6
1032.5
1843.6
3072.9
2314
1177
243.3
165.7
72
-110.5
-44.1
84.3
8.3
-26.4
139.4
-33.1
42.4

cash-flows.row.effect-of-forex-changes-on-cash

18.387.311.1-30.1
10.1
60.7
-121.4
52.3
85.1
-6.7
-37.7
-4.3
-4.9
3
-0.6
1.2
-0.3
0
0
0
0
0

cash-flows.row.net-change-in-cash

191.84488.4286.5342.8
-894.8
-2264.7
1845
-618.2
2843.9
78.7
459.5
-89.5
374.7
-32.6
-11.1
11.3
60.5
-27.3
-110.9
203.1
-3.3
13.6

cash-flows.row.cash-at-end-of-period

12298.852991.325032216.5
1873.7
2767.7
5022.1
3177.2
3795.3
951.4
871.2
411.7
501.2
126.5
159.1
170.2
158.9
98.4
125.7
236.5
33.4
36.7

cash-flows.row.cash-at-beginning-of-period

12107.0225032216.51873.7
2768.5
5032.4
3177.2
3795.3
951.4
872.7
411.7
501.2
126.5
159.1
170.2
158.9
98.4
125.7
236.5
33.4
36.7
23.1

cash-flows.row.operating-cash-flow

1730.182407.91269.62372.7
2082.1
1908.6
591.4
511.9
342.4
456
349.5
257.8
135.2
79.8
123.5
113.8
79.2
66.1
43.7
70.6
56.7
36.9

cash-flows.row.capital-expenditure

-1379.1-1131.2-1256.4-1231.2
-1433.5
-1099.4
-972.7
-651.2
-831.8
-585.5
-379.8
-315.2
-95.8
-56.9
-73.5
-92.5
-124
-47.8
-44.4
-26.8
-30.8
-52.7

cash-flows.row.free-cash-flow

351.081276.713.21141.6
648.7
809.2
-381.3
-139.3
-489.3
-129.6
-30.3
-57.5
39.5
23
50.1
21.3
-44.8
18.3
-0.7
43.8
25.9
-15.8

利润表行

Huapont Life Sciences Co., Ltd. 的收入与上期相比变化了 -0.124%。据报告, 002004.SZ 的毛利润为 4535.07。该公司的营业费用为 3032.17，与上年相比变化了 -9.489%. 折旧和摊销费用为 800.23，与上一会计期间相比变化了 0.114%. 营业费用报告为 3032.17，显示-9.489% 的同比变化。 销售和营销费用为 0, 其中 0.000% 与上年相比发生了变化。 基于近期数据的EBITDA为 0，同比增长-0.651%. 营业收入为 926.51，与上年相比变化了-0.651%. 净利润的变化率为 -0.732%。去年的净收入为302.12.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001

income-statement-row.row.total-revenue

11534.5311594.613232.412359.2
10876.4
10091.4
10573.6
9108.9
7092.8
6174.3
4866.7
4463.6
3877.4
638.1
541.2
544.5
575.7
492.4
285.2
273.5
272.5
240.4
200.2
174.1

income-statement-row.row.cost-of-revenue

7096.247059.57874.17605.6
6421.3
5395.8
6281.7
6195.1
4752.6
4040.4
3383.5
3297.1
2892.8
211.7
176.9
189.7
203.2
182.6
63.7
63.2
64.6
70.7
64
56.4

income-statement-row.row.gross-profit

4438.294535.15358.34753.6
4455
4695.6
4292
2913.8
2340.2
2133.9
1483.2
1166.6
984.5
426.4
364.3
354.8
372.6
309.7
221.6
210.3
208
169.7
136.2
117.6

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

412.1---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

432.26---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

1317.3---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

-30.25-34.1921.7784.4
599.4
646.4
636
418
83.6
-14.1
6.1
11.3
24.7
20.8
8.9
14.7
3.6
0.9
0.8
0.3
0.1
2.2
-0.2
-0.2

income-statement-row.row.operating-expenses

3043.23032.233503130
2896.7
3107.6
2865.7
1987.3
1501.2
1299.6
918.1
710.9
585.5
320.1
256.1
251.9
288.6
231
159.5
150.7
149
121.6
89.6
81.6

income-statement-row.row.cost-and-expenses

10139.4410091.711224.110735.6
9318
8503.4
9147.4
8182.3
6253.8
5340
4301.6
4008
3478.4
531.9
432.9
441.6
491.8
413.6
223.2
213.9
213.6
192.3
153.6
138

income-statement-row.row.interest-income

86.5485.28880.9
77.5
69.5
120.4
137.6
92.8
108.3
32.7
25.4
9.6
3.6
2.2
0
3.4
2.5
1.6
3
1
0.2
0.2
0.1

income-statement-row.row.interest-expense

345.8343.7434461.7
561.1
565.4
605
529.6
372.4
331.6
215.7
89.2
87.4
12.6
8
7.6
19.5
14.5
0.8
0.4
1.7
3.2
1.8
0.4

income-statement-row.row.selling-and-marketing-expenses

1317.3---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

-30.25-34.1-1031.2-607.9
-575.1
-683.1
-698.6
-457.4
-138.7
-77
-68.1
-65
47.1
219.6
43.3
44.5
18.9
167.3
6.5
2.5
-0.4
-3.2
-3
-0.1

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

-30.25-34.1921.7784.4
599.4
646.4
636
418
83.6
-14.1
6.1
11.3
24.7
20.8
8.9
14.7
3.6
0.9
0.8
0.3
0.1
2.2
-0.2
-0.2

income-statement-row.row.total-operating-expenses

-30.25-34.1-1031.2-607.9
-575.1
-683.1
-698.6
-457.4
-138.7
-77
-68.1
-65
47.1
219.6
43.3
44.5
18.9
167.3
6.5
2.5
-0.4
-3.2
-3
-0.1

income-statement-row.row.interest-expense

345.8343.7434461.7
561.1
565.4
605
529.6
372.4
331.6
215.7
89.2
87.4
12.6
8
7.6
19.5
14.5
0.8
0.4
1.7
3.2
1.8
0.4

income-statement-row.row.depreciation-and-amortization

671.4891.2800.2747.9
696.3
607.1
586.8
387.2
330.8
319.8
210.5
132.4
106.4
39.3
36.6
41.8
38
28.6
13.2
12.2
8.1
6.1
4.4
0.2

income-statement-row.row.ebitda-caps

1510.64---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

839.23926.52653.91893.9
1740.2
1832.4
1772.7
1139.2
657.8
752.8
481.4
384.8
425.9
306.1
149.9
137.4
99.6
246.8
70
63.2
58.9
47.4
44.2
36.2

income-statement-row.row.income-before-tax

808.99892.41622.71286
1165.1
1149.3
1074.1
681.8
700.3
757.3
497
390.7
446.1
325.8
151.5
147.4
102.8
246.1
69.7
62.8
58.8
47.3
43.8
36

income-statement-row.row.income-tax-expense

212.47215.5496361
270.1
217.4
251.3
88.1
88.6
100.5
51
73.7
75.3
17.4
16.4
18.1
12.7
23.4
10.8
10.9
11.9
7.7
7
4.9

income-statement-row.row.net-income

280.54302.11126.7925
895
931.9
822.8
507.9
566.9
636.6
429.2
302.4
332.4
305.3
132
127.7
88.8
206.5
58.4
52.5
47.6
39.9
37.3
31.1
类似股票
您可能还对以下内容感兴趣：
CHSYF
China Medical System Holdings Limited.
0.9313 USD
PNK
TLLTF
TILT Holdings Inc..
0.0322 USD
PNK
600479.SS
ZhuZhou QianJin Pharmaceutical Co.,Ltd.
10.92 CNY
SHH
WOCKPHARMA.BO
Wockhardt Limited.
569.55 INR
BSE
185750.KS
Chong Kun Dang Pharmaceutical Corp..
100300 KRW
KSC
2196.HK
Shanghai Fosun Pharmaceutical (Group) Co., Ltd..
12.44 HKD
HKSE
002693.SZ
Hainan Shuangcheng Pharmaceuticals Co., Ltd..
5.26 CNY
SHZ
ERIS.NS
Eris Lifesciences Limited.
890.25 INR
NSE
300601.SZ
Shenzhen Kangtai Biological Products Co., Ltd..
22.39 CNY
SHZ
TKPHF
Takeda Pharmaceutical Company Limited.
26.616 USD
PNK
MVP.AX
Medical Developments International Limited.
0.61 AUD
ASX

常见问题

什么是 Huapont Life Sciences Co., Ltd. (002004.SZ) 总资产是多少？

Huapont Life Sciences Co., Ltd. (002004.SZ) 总资产为 30727396560.000.

什么是企业年收入？

年收入为 5657008739.000.

企业利润率是多少？

公司利润率为 0.385.

什么是公司自由现金流？

自由现金流为 0.177.

什么是企业净利润率？

净利润率为 0.024.

企业总收入是多少？

总收入为 0.073.

什么是 Huapont Life Sciences Co., Ltd. (002004.SZ) 净利润？{{符号}}净利润（净收入）是多少？

净利润（净收入）为 302122026.000.

公司总债务是多少？

债务总额为 8625844451.000.

营业费用是多少？

运营支出为 3032172071.000.

公司现金是多少？

企业现金为 4112423354.000.